ShareSoc42 Videos

0

50:59

Open Orphan (ORPH) ShareSoc presentation 11th May 2020

Open Orphan Executive Chairman Cathal Friel presents an update at the ShareSoc Growth Company webinar 11th May 2020. Introduction from Mike Dennis, ShareSoc – 00:23 Cathal Friel, Executive Chairman, Open Orphan. Introduction – 00:55 About Open Orphan – 01:33 Management team – 08:39 Complementary Services Business – 10:26 World’s first Coronavirus challenge model – 11:28 […]

12th May 2020

0

37:57

Open Orphan (ORPH) presentation at ShareSoc March 2020

By Cathal Friel, Exec Chair Friel gives an overview of Open Orphan, how it was formed, the business, hVIVO and its work with virus testing, plus comments on COVID-19. Introduction – 00:18 Open Orphan management – 03:00 History and acquisitions – 04:15 High value & longer-term contracts – 08:32 Open Orphan – 09:22 Genomic database […]

16th March 2020

0

21:29

Diaceutics (DXRX) presentation at ShareSoc London, February 2020

Presented by Peter Keeling, CEO Introduction – 00:20 What is Precision Medicine? – 02:05 Patient pathway – 04:20 What Diaceutics do – 07:57 The market – 11:05 Key metrics – 13:50 Diagnostic commercialisation platform – 17:16 Revenue analysis – 19:01 Diaceutics PLC is a United Kingdom-based data analytics and implementation services company which services the […]

27th February 2020

0

31:13

ECSC Group (ECSC) presentation at ShareSoc October 2019

by Ian Mann, CEO and Founder Introduction – 00:18 What ECSC do – 01:41 The market – 08:09 New cyber security vulnerabilities – 09:37 Major GDPR fines – 10:56 Jan-June 19 financial performance -15:10 Organic revenue growth – 18:11 KPIs – 19:00 Outlook – 20:08 Summary – 21:10 Q&A – 21:50 ECSC Group plc is […]

25th October 2019

0

34:57

Trinity Exploration & Production (TRIN) H1 results presentation at ShareSoc

Jeremy Bridglalsingh, Managing Director & CFO talks through the latest results (half year ending 30th June 2019), released 10th September 2019. Why Trinidad? – 00:18 Who is Trinity? And management shareholdings – 02:49 Asset Summaries – 04:22 2019 Interim results & post period highlights – 05:56 Increasing margins & financial resilience – 11:10 Margin drivers […]

16th September 2019

0

36:40

Open Orphan (ORPH) at ShareSoc September 2019

Presentation by Cathal Friel, Co-Founder ORPH came out of a reverse takeover of Venn Life Sciences earlier this year. Cathal Friel outlines what they’re up to, and their vision. Introduction – 00:18 A pharma services company – 02:02 The founders – 03:14 The orphan drug sector – 06:48 Combining high-margin pharma with digital & data […]

16th September 2019

0

41:01

PCF (PCF) ShareSoc presentation June 2019

By Scott Maybury, CEO Introduction – 00:18 Company overview – 00:55 Operational highlights – 04:51 Financial highlights – 09:24 Business lines – 11:02 2019 Achievements – 17:30 Outlook – 19:27 Strategic objectives – 22:06 Q&A – 24:33 PCF Group plc, formerly Private & Commercial Finance Group plc, is engaged in banking business. The Company offers […]

20th June 2019

0

42:15

Sirius Real Estate (SRE) Investor presentation at ShareSoc 10th April 2019

Presentation by Andrew Coombs CEO. Sirius Real Estate Limited (Sirius) is a real estate holding company. The Company is engaged in the investment in and operation and development of commercial property to provide smart and flexible workspace in Germany. The Company has a portfolio of approximately 60 business parks across Germany. The Company invests in […]

24th April 2019

0

31:47

ECSC Group plc (ECSC) Investor presentation, at ShareSoc March 13.3.19, by Ian Mann, CEO.

ECSC Group plc is a United Kingdom-based information and cyber security service provider. The Company offers a range of cyber security solutions and services to the sectors, including education, retail, legal, financial and local authorities. It offers services to e-commerce start-ups and global organisations. Its PROTECT division delivers the ECSC PCI DSS certified Security Operations […]

19th March 2019

0

37:07

Avacta (AVCT) presentation at ShareSoc London 13th March 2019

By Dr Alastair Smith, Chief Executive Shaping the Future of Cancer Therapy Dr Smith gives a comprehensive overview of Avacta, followed by Q&As. Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and […]

15th March 2019